Search results
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 6 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 7 days agoNovavax has become a safer buy of late COVID-19 vaccine maker Novavax can be ...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 7 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 13 hours agoThe company also just unveiled promising results for its updatedCovid vaccine. The next-generation...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 6 days ago“Based on the totality of the evidence, on June 6, 2024, FDA initially advised the manufacturers of the licensed and authorized COVID-19 vaccines ...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 3 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?